Walleye Capital LLC Cardiff Oncology, Inc. Transaction History

Walleye Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$1.17 - $2.61 $144,266 - $321,826	-123,305 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.11 - $7.25 $260,173 - $893,961	123,305 New	123,305 $306,000
Q4 2021 Mar 03, 2022	SELL	$5.18 - $7.24 $73,789 - $103,133	-14,245 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$5.01 - $7.58 $71,367 - $107,977	14,245 New	14,245 $95,000

12.3M

813K

91.1K

Ticker CRDF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,334,900
Market Cap $170M
Description
Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; meta...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.